Literature DB >> 6245892

Plasma cyclic nucleotide responses to insulin-induced hypoglycaemia and methacholine in patients with hyperthyroidism.

F Okada, H Ide, S Hata, M Honma, M Ui.   

Abstract

The effect of insulin-induced hypoglycaemia and methacholine on plasma cAMP and cGMP levels was studied in normal volunteers, hyperthyroid and hypothyroid patients. A significant positive correlation existed between the maximal increase in plasma cAMP and the maximal decrease in plasma glucose in normals during insulin-induced hypoglycaemia. Therefore, the plasma cAMP response is considered to be dependent on the degree of hypoglycaemia, rather than the dose of insulin. The cAMP response to hypoglycaemia was significantly higher in hyperthyroid patient, and was lower in patients with hypothyroidism than in normals. The cAMP response of the hyperthyroid patients was normalized when their hyperthyroidism was controlled after 3 months of treatment. The plasma level of cGMP was slightly elevated during hypoglycaemia, but there was no significant difference between controls and hyperthyroid patients. The cGMP response to methacholine, which is probably mediated by cholinergic receptors, was significantly potentiated in hyperthyroid patients. The cAMP response, which is presumably dependent on endogenous catecholamines secreted during methacholine-induced hypotension, was also enhanced in hyperthyroid patients. It is likely that beta-adrenergic receptor responses and cholinergic receptor responses are both enhanced in hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245892     DOI: 10.1111/j.1365-2362.1980.tb00014.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  3 in total

1.  Heart failure in thyrotoxicosis, an approach to management.

Authors:  R P Choudhury; J MacDermot
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

2.  Hemodynamic and tissue oxygenation responses to exercise and beta-adrenergic blockade in patients with hyperthyroidism.

Authors:  Maristela C Monachini; Silvia G Lage; Miguel A N Ran; Rita H A Cardoso; Caio Medeiros; Bruno Caramelli; Andrei C Sposito; José A F Ramires
Journal:  Clin Cardiol       Date:  2004-07       Impact factor: 2.882

3.  Plasma and urine cyclic nucleotide levels in patients with hyperthyroidism and hypothyroidism.

Authors:  M Peracchi; F Bamonti-Catena; L Lombardi; E Reschini; V Toschi; A T Maiolo; E E Polli
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.